Bone health in children and adolescents after allogeneic stem cell transplantation: High prevalence of vertebral compression fractures

Cancer

Volumn 110, Issue 2, 2007, Pages 442-451

  Taskinen, Mervi ^a   Saarinen Pihkala, Ulla M ^a   Hovi, Liisa ^a   Vettenranta, Kim ^a   Mäkitie, Outi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bone mineral density; Childhood; Stem cell transplantation; Vertebral fracture

Indexed keywords

CALCIUM PHOSPHATE; CYCLOSPORIN; ESTROGEN; METHOTREXATE; PARATHYROID HORMONE; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE DENSITY; BONE MINERAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPRESSION FRACTURE; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PUBERTY; SCORING SYSTEM; VERTEBRA FRACTURE;

ADOLESCENT; BONE AND BONES; BONE DENSITY; CHILD; DENSITOMETRY, X-RAY; HUMANS; NEOPLASMS; PREVALENCE; SPINAL FRACTURES; STEM CELL TRANSPLANTATION;

EID: 34547179512     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22796     Document Type: Article

References (39)

1. Sochett EB, Makitie O. Osteoporosis in chronically ill children. Ann Med. 2005;37:286-294.
2. Rodino MA, Shane E. Osteoporosis after organ transplantation. Am J Med. 1998;104:459-469.
3. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis Int. 2003;14:617-630.
4. Valimaki MJ, Kinnunen K, Volin L, et al. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 1999;23:355-361.
5. Schulte C, Beelen DW, Schaefer UW, Mann K. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporosis Int. 2000;11:344-353.
6. Buchs N, Helg C, Collao C, et al. Allogneic bone marrow transplantation is associated with preferential femoral neck bone loss. Osteoporosis Int. 2001;12:880-886.
7. Taskinen M, Kananen K, Valimaki MJ, et al. Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood. Pediatr Transplant. 2006;10:90-97.
8. Lee WY, Cho SW, Oh ES, et al. The effect of bone marrow transplantation on the osteoblastic differentation of human bone marrow stromal cells. J Clin Endocrinol Metab. 2002;87:329-335.
9. Helenius I, Remes V, Salminen S, et al. Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res. 2006;21:380-387.
10. Kananen K, Volin L, Tahtela R, Laitinen K, Ruutu T, Valimaki MJ. Recovery of bone mass and normalization of bone turn-over in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;29:33-39.
11. Nysom K, Holm K, Fleischer Michaelsen K, et al. Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant. 2000;25:191-196.
12. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
13. Valta H, Lahdenne P, Jalanko H, Aalto K, Makitie O. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34:831-836.
14. Tanner JM.Growth and endocrinology of the adolescent. In: Gardner LI, editor. Endocrine and Genetic Diseases of Childhood. Philadelphia: W.B. Saunders Co.; 1969.
15. Sorva R, Lankinen S, Tolppanen EM, Perheentupa J. Variation of growth in height and weight of children. II. After infancy. Acta Paediatr Scand. 1990;79:498-506.
16. Greulich WW, Pyle SI. Radiographic Atlas of the Skeletal Development of the Hand and Wrist. 2nd ed. Palo Alto, CA: Stanford University Press; 1959.
17. Makitie O, Doria AS, Henriques F, et al. Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr. 2005;146:395-401.
18. Bhatia S, Ramsay NKC, Weisdorf D, Griffiths H, Robison LL. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant. 1998;22:87-90
19. Daniels MW, Wilson DM, Paguntalan HG, Hoffman AR, Bachrach LK. Bone mineral density in pediatric transplant recipients. Transplantation. 2003;76:673-678.
20. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JR Osteoporosis after cardiac transplantation. Am J Med. 1993;94:257-264.
21. Reddy SR Junewick JJ, Backstrom JW. Distribution of spinal fractures in children: does age, mechanism of injury, or gender play a significant role? Pediatr Radiol. 2003;33:776-781.
22. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures.The Fracture Intervention Trial Research Group. Bone. 1999;25:613-619.
23. Hans D, Fuerst T, Lang T, et al. How can we measure bone quality? Baillieres Clin Rheumatol. 1997;1:495-515.
24. Stern JM, Chesnut CH 3rd, Bruemmer B, et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant. 1996;17:395-400.
25. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res. 1996;11:1-7.
26. Jaksch M. Mattsson J. The pathophysiology of acute graft-versus-host disease. Scand J Immunol. 2005;61:398-409.
27. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med. 1995;332:305-311.
28. Lee WY, Baek KH, Rhee EJ, Tae HJ, et al. Impact of circulating bone-resorbing cytokines on subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant. 2004;34:89-94.
29. Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33:435-441.
30. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocrine Rev. 2002;23:279-302.
31. Monson JP, Drake WM, Carroll PV, Weaver JU, Rodriguez-Arnao J, Savage MO. Influence of growth hormone on accretion of bone mass. Hormone Res. 2002;58 (suppl 1):52-56.
32. Olney RC. Regulation of bone mass by growth hormone. Med Pediatr Oncol. 2003;41:228-234.
33. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 1992;74:118-123.
34. Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res. 1999;14:633-643.
35. Leonard MB, Propert KJ, Zemel BS, Stallings VA, Feldman HI. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr. 1999;135:182-188.
36. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;314:1-27.
37. Schulte CMS, Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood, 2004;103:3635-3643.
38. Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MJ. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab. 2005;90:3877-3885.
39. Thornton J, Ashcroft DM, Muqhal MZ, Elliott RA, O'Neill TW, Symmons D. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis. Arch Dis Child. 2006;91:753-761.